| 发明名称 |
Pharmaceutical Compositions Comprising Multi-Component Crystalline Particles Suitable for Use in Inhalation Therapy |
| 摘要 |
Pharmaceutical compositions comprising multi-component crystalline particles suitable for use in inhalation therapy and for delivery by oral or nasal inhalation are provided, wherein said compositions additionally comprise particles of at least one additional active agent. Also provided are methods of preparation of the compositions and their use in medicine. |
| 申请公布号 |
US2015366804(A1) |
申请公布日期 |
2015.12.24 |
| 申请号 |
US201414762884 |
申请日期 |
2014.01.29 |
| 申请人 |
Prosonix Limited |
发明人 |
Burns John;Parikh Dipesh |
| 分类号 |
A61K9/00;A61K31/56;A61K9/19;A61K31/137;A61K31/192;A61K9/16;A61K31/40 |
主分类号 |
A61K9/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A composition for inhalation therapy comprising multi-component crystalline particles and also particles of fluticasone propionate, wherein the multi-component crystalline particles comprise glycopyrronium bromide and salmeterol xinafoate (GB-SX) as active ingredients and are substantially free of excipients and agents other than the active ingredients. |
| 地址 |
London GB |
